Global Sodium Channel Blockers Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium Channel Blockers Market Research Report 2024
Sodium Channel Blockers are a class of drugs that selectively block sodium channels and inhibit the influx of sodium ions. The degree of drug blocking of sodium channels is related to heart rate, membrane potential of cardiomyocytes and the reactivation time constant of the channel.
According to Mr Accuracy reports’s new survey, global Sodium Channel Blockers market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029.
Key manufacturers engaged in the Sodium Channel Blockers industry include SK biopharmaceuticals, Biogen, Parion Sciences, AlphaNavi Pharma, WEX, Vertex Pharmaceuticals, RaQualia Pharma and KBP Biosciences, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sodium Channel Blockers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sodium Channel Blockers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Channel Blockers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
SK biopharmaceuticals
Biogen
Parion Sciences
AlphaNavi Pharma
WEX
Vertex Pharmaceuticals
RaQualia Pharma
KBP Biosciences
Segment by Type
Class IA (Quinidine, Procainamide, etc.)
Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
Class IC (Propafenone, Flecainide, etc.)
Injection
Oral
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Channel Blockers report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Sodium Channel Blockers market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029.
Key manufacturers engaged in the Sodium Channel Blockers industry include SK biopharmaceuticals, Biogen, Parion Sciences, AlphaNavi Pharma, WEX, Vertex Pharmaceuticals, RaQualia Pharma and KBP Biosciences, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sodium Channel Blockers were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sodium Channel Blockers market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium Channel Blockers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
SK biopharmaceuticals
Biogen
Parion Sciences
AlphaNavi Pharma
WEX
Vertex Pharmaceuticals
RaQualia Pharma
KBP Biosciences
Segment by Type
Class IA (Quinidine, Procainamide, etc.)
Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
Class IC (Propafenone, Flecainide, etc.)
Segment by Application
Injection
Oral
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Channel Blockers report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source